Advertisement
Advertisement
HCAT
Health Catalyst, Inc Common Stock
1.10
USDSponsored
0.00
0.00%
Mar 25, 15:41 UTC -4
Closed
Pre-Market
1.09
-0.01
-0.45%
HCAT Earnings Reports
Positive Surprise Ratio
HCAT beat 23 of 27 last estimates.
85%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$70.55M
/$0.03
Implied change from Q4 25 (Revenue/ EPS)
-5.52%
/-62.50%
Implied change from Q1 25 (Revenue/ EPS)
-11.15%
/+200.00%
Health Catalyst, Inc Common Stock earnings per share and revenue
On Mar 12, 2026, HCAT reported earnings of 0.08 USD per share (EPS) for Q4 25, missing the estimate of 0.09 USD, resulting in a -13.79% surprise. Revenue reached 74.68 million, compared to an expected 75.46 million, with a -1.04% difference. The market reacted with a -2.44% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 10 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 70.55 million USD, implying an decrease of -62.50% EPS, and decrease of -5.52% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
Mar 12, 2026 For Q4 25
Estimate
-Actual
-$0.01
Surprise
-
CareCloud, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.03
Actual
$0.03
Surprise
-15.97%
Nyxoah SA Ordinary Shares
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.58
Surprise
-5.51%
Neuraxis, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.21
Actual
-$0.17
Surprise
+22.48%
Heartflow, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.12
Surprise
+30.31%
Heartbeam, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.14
Surprise
-0.72%
HeartSciences Inc. Common Stock
Report Date
Mar 16, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.63
Surprise
+27.34%
FAQ
What were Health Catalyst, Inc Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Health Catalyst, Inc Common Stock reported EPS of $0.08, missing estimates by -13.79%, and revenue of $74.68M, -1.04% below expectations.
How did the market react to Health Catalyst, Inc Common Stock's Q4 2025 earnings?
The stock price moved down -2.44%, changed from $2.46 before the earnings release to $2.40 the day after.
When is Health Catalyst, Inc Common Stock expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Health Catalyst, Inc Common Stock's next earnings report?
Based on 10
analysts, Health Catalyst, Inc Common Stock is expected to report EPS of $0.03 and revenue of $70.55M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement